Association of PTPN22 haplotypes with type 1 diabetes in the Japanese population

Human Immunology

Volumn 71, Issue 8, 2010, Pages 795-798

  Taniyama, Matsuo ^a   Maruyama, Taro ^b   Tozaki, Teruaki ^c   Nakano, Yasuko ^c   Ban, Yoshiyuki ^d  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^b Saitama Social Insurance Hospital   (Japan)

^c SHOWA UNIVERSITY   (Japan)

^d SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Genetic susceptibility; Haplotype; PTPN22; Type 1 diabetes

Indexed keywords

NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22;

ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 1; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; JAPAN; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22;

EID: 77954758554     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.05.016     Document Type: Article

References (28)

1. Notokins L., Lernmark Å Autoimmune type 1 diabetes: Resolved and unresolved. J Clin Invest 2001, 108:1247-1252.
2. Pugliese A., Eisenbarth G.S. Type 1 diabetes mellitus of man: genetic susceptibility and resistance. Adv Exp Med Biol 2004, 552:170-203.
3. She J.X. Susceptibility to type 1 diabetes: HLA-DQ and DR revisited. Immunol Today 1996, 17:323-329.
4. Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661-678. Wellcome Trust.
5. Todd J.A., Walker N.M., Cooper J.D., Smyth D.J., Downes K., Plagnol V., et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007, 39:857-864.
6. T1D Base, Last accessed 2010. http://www.T1DBase.org.
7. Howson J.M.M., Walker N.M., Smyth D.J., Todd J.A. Analysis of 19 genes for association with type I diabetes in the Type I Diabetes Genetics Consortium families. Genes Immun 2009, 10:S74-S84. Type I Diabetes Genetics Consortium.
8. Podolsky R., Prasad Linga-Reddy M.V., She J.-X. Analyses of multiple single-nucleotide polymorphisms in the SUMO4/IDDM5 region in affected sib-pair families with type I diabetes. Genes Immun 2009, 10:S16-S20. Type I Diabetes Genetics Consortium.
9. Baranzini S.E. The genetics of autoimmune diseases: A networked perspective. Curr Opin Immunol 2009, 21:596-605.
10. Bottini N., Musumeci L., Alonso A., Rahmouni S., Nika K., Rostamkhani M., et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004, 36:337-338.
11. Bottini N., Vang T., Cucca F., Mustelin T. Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Semin Immunol 2006, 18:207-213.
12. Ban Y., Tozaki T., Taniyama M., Tomita M., Ban Y. The codon 620 single nucleotide polymorphism of the protein tyrosine phosphatase-22 gene does not contribute to autoimmune thyroid disease susceptibility in the Japanese. Thyroidology 2005, 15:1115-1118.
13. Ikari K., Momohara S., Inoue E., Tomatsu T., Hara M., Yamanaka H., Kamatani N. Haplotype analysis revealed no association between the PTPN22 gene and RA in a Japanese population. Rheumatology 2006, 45:1345-1348.
14. Kawasaki E., Awata T., Ikegami H., Kobayashi T., Maruyama T., Nakanishi K., et al. Systematic search for single nucleotide polymorphisms in a lymphoid tyrosine phosphatase gene (PTPN22): Association between a promoter polymorphism and type 1 diabetes in Asian populations. Am J Med Genet 2006, 140:586-593.
15. Cinek O., Hradsky O., Ahmedov G., Slavcev A., Kolouskova S., Kulich M., Sumnik Z. No independent role of the -1123 G>C and+2740 A>G variants in the association of PTPN22 with type 1 diabetes and juvenile idiopathic arthritis in two Caucasian populations. Diabetes Res Clin Pract 2007, 76:297-303.
16. Viken M.K., Olsson M., Flåm S.T., Førre O., Kvien T.K., Thorsby E., Lie B.A. The PTPN22 promoter polymorphism -1123G>C association cannot be distinguished from the 1858C>T association in a Norwegian rheumatoid arthritis material. Tissue Antigens 2007, 70:190-197.
17. Carlton V.E., Hu X., Chokkalingam A.P., Schrodi S.J., Brandon R., Alexander H.C., et al. PTPN22 genetic variation: Evidence for multiple variants associated with rheumatoid arthritis. Am J Hum Genet 2005, 77:567-581.
18. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 1997.
19. SNPAlyze, Last accessed 2010. http://www.dynacom.co.jp/e/products/package/snpalyze/.
20. Baschal E.E., Eisenbarth G.S. Extreme genetic risk for type 1A diabetes in the post-genome era. J Autoimmun 2008, 31:1-6.
21. Ikegami H., Kawabata Y., Noso S., Fujisawa T., Ogihara T. Genetics of type 1 diabetes in Asian and Caucasian populations. Diabetes Res Clin Pract 2007, 77(Suppl 1):S116-S121.
22. Vang T., Congia M., Macis M.D., Musumeci L., Orrú V., Zavattari P., et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 2005, 37:1317-1319.
23. Onengut-Gumuscu S., Buckner J.H., Concannon P. A haplotype-based analysis of the PTPN22 locus in type 1 diabetes. Diabetes 2006, 55:2883-2889.
24. Zoledziewska M., Perra C., OrrÚ V., Moi L., Frongia P., Congia M., et al. Further evidence of a primary, causal association of the PTPN22 620W variant with type 1 diabetes. Diabetes 2008, 57:229-234.
25. Heward J.M., Brand O.J., Barrett J.C., Carr-Smith J.D., Franklyn J.A., Gough S.C. Association of PTPN22 haplotypes with Graves' disease. J Clin Endocrinol Metab 2007, 92:685-690.
26. Ichimura M, Kaku H, Fukutani T, Koga H, Mukai T, Miyake I, et al. Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves' disease in a Japanese population. Thyroidology:18:625-30.
27. Hinks A., Eyre S., Barton A., Thomson W., Worthington J. Investigation of genetic variation across the protein tyrosine phosphatase gene in patients with rheumatoid arthritis in the UK. Ann Rheum Dis 2007, 66:683-686.
28. Orrú V., Tsai S.J., Rueda B., Fiorillo E., Stanford S.M., Dasgupta J., et al. A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus. Hum Mol Genet 2009, 18:569-579.